Crab used by Royal Marsden to test UK's most precise radiotherapy machine

Crab: It was used to successfully test the UK’s most precise radiotherapy machine
Ross Lydall @RossLydall9 February 2017

A crab bought at Wimbledon farmers’ market has been used to successfully test the UK’s most precise radiotherapy machine.

The MR Linac machine has been installed at the Sutton health campus shared by the Royal Marsden hospital and the Institute of Cancer Research.

Prior to the first patients being treated in about six months, experts wanted to trial the capabilities of the machine, which is the first in the country to combine a MRI scanner with X-ray therapy.

This ensures radiotherapy is delivered as precisely as possible to tumours such as prostate, lung, cervical, bowel and breast cancers that move as the patient breathes or are barely visible to current technology.

It also prevents damage being caused by the powerful beams to non-cancerous areas.

Prescise: The new machine

Delivering radiation in “real time” also avoids the need to rely on scans that might have been taken a week or two earlier.

The crab, bought at the market at Wimbledon Park primary school, was missing a leg and had already been cooked when it was scanned. It was not irradiated during the test.

It was chosen because it is the zodiac sign for cancer, and because it features as part of the Marsden’s logo.

When MR Linac machines have been trialled in Texas a T-bone steak was used. In the Netherlands a tulip was scanned.

It has cost in excess of £10 million to install the machine in Sutton. Professor Paul Workman, ICR chief executive, said: “The MR Linac is our flagship project in a programme of research to apply state-of-the-art technology to create smarter, kinder forms of radiotherapy.”

Professor Uwe Oelfke, head of the department of physics at the ICR and Marsden, said: “By doing accurate patient imaging at the same time as delivery of radiotherapy — rather than as separate steps — we aim to significantly improve treatment for patients with hard-to-treat cancers including lung cancer.”

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in